Cytokinesis-blocked micronucleus cytome assay and spectral karyotyping as methods for identifying chromosome damage in a lung cancer case-control population

Genes Chromosomes and Cancer

Volumn 52, Issue 7, 2013, Pages 694-707

  Lloyd, Stacy M ^a   Lopez, Mirtha ^a   El Zein, Randa ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; FRAGILE HISTIDINE TRIAD PROTEIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; POLY(ADENOSINE DIPHOSPHATE RIBOSE); PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER RISK; CHROMOSOME 1; CHROMOSOME 13; CHROMOSOME 16; CHROMOSOME 17; CHROMOSOME 19; CHROMOSOME 22; CHROMOSOME 3; CHROMOSOME 4; CHROMOSOME 9; CHROMOSOME DAMAGE; CONTROLLED STUDY; CYTOGENETICS; CYTOKINESIS; DNA DAMAGE; ETHNICITY; FEMALE; GENDER; HUMAN; HUMAN CELL; LUNG CANCER; LUNG CARCINOGENESIS; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RACE; SMOKING; SPECTRAL KARYOTYPING; X CHROMOSOME;

AGED; CASE-CONTROL STUDIES; CHROMOSOME ABERRATIONS; CYTOKINESIS; DNA DAMAGE; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LUNG NEOPLASMS; MALE; MICRONUCLEUS TESTS; MIDDLE AGED; NITROSAMINES;

NICOTIANA TABACUM;

EID: 84877921651     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.22065     Document Type: Article

References (56)

1. Abdel-Rahman SZ, El-Zein RA. 2000. The 399gln polymorphism in the DNA repair gene Xrcc1 modulates the genotoxic response induced in human lymphocytes by the tobacco-specific nitrosamine Nnk. Cancer Lett 159:63-71.
2. Adams JD, O'Mara-Adams KJ, Hoffmann D. 1987. Toxic and carcinogenic agents in undiluted mainstream smoke and sidestream smoke of different types of cigarettes. Carcinogenesis 8:729-731.
3. American Cancer Society. 2011. Cancer Facts and Figures 2011. Atlanta. 1-60 p.
4. Amos CI, Gorlov IP, Dong Q, Wu X, Zhang H, Lu EY, Scheet P, Greisinger AJ, Mills GB, Spitz MR. 2010. Nicotinic acetylcholine receptor region on chromosome 15q25 and lung cancer risk among african americans: A case-control study. J Natl Cancer Inst 102:1199-1205.
5. Baker DJ, van Deursen JM. 2010. Chromosome missegregation causes colon cancer by Apc loss of heterozygosity. Cell Cycle 9:1711-1716.
6. Balsara BR, Testa JR. 2002. Chromosomal imbalances in human lung cancer. Oncogene 21:6877-6883.
7. Berwick M, Vineis P. 2000. Markers of DNA repair and susceptibility to cancer in humans: An epidemiologic review. J Natl Cancer Inst 92:874-897.
8. Bonassi S, Abbondandolo A, Camurri L, Dal Pra L, De Ferrari M, Degrassi F, Forni A, Lamberti L, Lando C, Padovani P, et al. 1995. Are chromosome aberrations in circulating lymphocytes predictive of future cancer onset in humans? Preliminary results of an Italian cohort study. Cancer Genet Cytogenet 79:133-135.
9. Bonassi S, Znaor A, Ceppi M, Lando C, Chang WP, Holland N, Kirsch-Volders M, Zeiger E, Ban S, Barale R, Bigatti MP, Bolognesi C, Cebulska-Wasilewska A, Fabianova E, Fucic A, Hagmar L, Joksic G, Martelli A, Migliore L, Mirkova E, Scarfi MR, Zijno A, Norppa H, Fenech M. 2007. An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans. Carcinogenesis 28:625-631.
10. Bonassi S, El-Zein R, Bolognesi C, Fenech M. 2011. Micronuclei frequency in peripheral blood lymphocytes and cancer risk: Evidence from human studies. Mutagenesis 26:93-100.
11. Bouhamyia L, Chantot-Bastaraud S, Zaidi S, Roynard P, Prengel C, Bernaudin JF, Fleury-Feith J. 2007. Immunolocalization and cell expression of lung resistance-related protein (Lrp) in normal and tumoral human respiratory cells. J Histochem Cytochem 55:773-782.
12. Centers for Disease Control and Prevention. 2010. Racial/Ethnic Disparities and Geographic Differences in Lung Cancer Incidence - 38 States and the District of Columbia, 1998-2006. Atlanta. 1433-1438 p.
13. DeMarini DM. 2004. Genotoxicity of tobacco smoke and tobacco smoke condensate: A review. Mutat Res 567:447-474.
14. Di YM, Chow VD, Yang LP, Zhou SF. 2009. Structure, function, regulation and polymorphism of human cytochrome P450 2a6. Curr Drug Metab 10:754-780.
15. Doubre H, Cesari D, Mairovitz A, Benac C, Chantot-Bastaraud S, Dagnon K, Antoine M, Danel C, Bernaudin JF, Fleury-Feith J. 2005. Multidrug resistance-associated protein (Mrp1) is overexpressed in DNA aneuploid carcinomatous cells in non-small cell lung cancer (Nsclc). Int J Cancer 113:568-574.
16. El-Zein R, Abdel-Rahman SZ, Conforti-Froes N, Alpard SK, Zwischenberger JB. 2000. Chromosome aberrations as a predictor of clinical outcome for smoking associated lung cancer. Cancer Lett 158:65-71.
17. El-Zein R, Vral A, Etzel CJ. 2011. Cytokinesis-blocked micronucleus assay and cancer risk assessment. Mutagenesis 26:101-106.
18. El-Zein RA, Schabath MB, Etzel CJ, Lopez MS, Franklin JD, Spitz MR. 2006. Cytokinesis-blocked micronucleus assay as a novel biomarker for lung cancer risk. Cancer Res 66:6449-6456.
19. El-Zein RA, Fenech M, Lopez MS, Spitz MR, Etzel CJ. 2008. Cytokinesis-blocked micronucleus cytome assay biomarkers identify lung cancer cases amongst smokers. Cancer Epidemiol Biomarkers Prev 17:1111-1119.
20. Fenech M, Morley AA. 1985. Measurement of micronuclei in lymphocytes. Mutat Res 147:29-36.
21. Fenech M, Chang WP, Kirsch-Volders M, Holland N, Bonassi S, Zeiger E. 2003. Humn project: Detailed description of the scoring criteria for the cytokinesis-block micronucleus assay using isolated human lymphocyte cultures. Mutat Res 534:65-75.
22. Fenech M. 2007. Cytokinesis-block micronucleus cytome assay. Nat Protoc 2:1084-1104.
23. Fenech M, Kirsch-Volders M, Natarajan AT, Surralles J, Crott JW, Parry J, Norppa H, Eastmond DA, Tucker JD, Thomas P. 2011. Molecular mechanisms of micronucleus, nucleoplasmic bridge and nuclear bud formation in mammalian and human cells. Mutagenesis 26:125-132.
24. Ganem NJ, Pellman D. 2012. Linking abnormal mitosis to the acquisition of DNA damage. J Cell Biol 199:871-881.
25. Garnis C, Campbell J, Davies JJ, Macaulay C, Lam S, Lam WL. 2005. Involvement of multiple developmental genes on chromosome 1p in lung tumorigenesis. Hum Mol Genet 14:475-482.
26. Haga Y, Hiroshima K, Iyoda A, Kohno H, Shibuya K, Iizasa T, Fujisawa T, Ohwada H. 2005. Frequency of loss of heterozygosity at 3 P, 9 P, 13 Q, and 17 P is related to proliferative activity in smokers with stage I non-small cell lung cancer. Thorac Cardiovasc Surg 53:114-117.
27. Hagmar L, Brogger A, Hansteen IL, Heim S, Hogstedt B, Knudsen L, Lambert B, Linnainmaa K, Mitelman F, Nordenson I, et al. 1994. Cancer risk in humans predicted by increased levels of chromosomal aberrations in lymphocytes: Nordic study group on the health risk of chromosome damage. Cancer Res 54:2919-2922.
28. Hecht SS, Hoffmann D. 1989. The relevance of tobacco-specific nitrosamines to human cancer. Cancer Surv 8:273-294.
29. Hecht SS. 1999. DNA adduct formation from tobacco-specific N-nitrosamines. Mutat Res 424:127-142.
30. Hecht SS. 2002. Human urinary carcinogen metabolites: Biomarkers for investigating tobacco and cancer. Carcinogenesis 6:907-922.
31. Hill CE, Affatato AA, Wolfe KJ, Lopez MS, Hallberg CK, Canistro D, Abdel-Rahman SZ. 2005. Gender differences in genetic damage induced by the tobacco-specific nitrosamine Nnk and the influence of the Thr241met polymorphism in the Xrcc3 gene. Environ Mol Mutagen 46:22-29.
32. Holland AJ, Cleveland DW. 2012. Losing balance: The origin and impact of aneuploidy in cancer. EMBO Rep 13:501-514.
33. Hu Z, Wu C, Shi Y, Guo H, Zhao X, Yin Z, Yang L, Dai J, Hu L, Tan W, Li Z, Deng Q, Wang J, Wu W, Jin G, Jiang Y, Yu D, Zhou G, Chen H, Guan P, Chen Y, Shu Y, Xu L, Liu X, Liu L, Xu P, Han B, Bai C, Zhao Y, Zhang H, Yan Y, Ma H, Chen J, Chu M, Lu F, Zhang Z, Chen F, Wang X, Jin L, Lu J, Zhou B, Lu D, Wu T, Lin D, Shen H. 2011. A genome-wide association study identifies two new lung cancer susceptibility Loci at 13q12.12 and 22q12.2 in Han Chinese. Nat Genet 43:792-796.
34. Kim YH, Kwei KA, Girard L, Salari K, Kao J, Pacyna-Gengelbach M, Wang P, Hernandez-Boussard T, Gazdar AF, Petersen I, Minna JD, Pollack JR. 2010. Genomic and functional analysis identifies Crkl as an oncogene amplified in lung cancer. Oncogene 29:1421-1430.
35. Kirsch-Volders M, Plas G, Elhajouji A, Lukamowicz M, Gonzalez L, Vande Loock K, Decordier I. 2011. The in vitro Mn assay in 2011: Origin and fate, biological significance, protocols, high throughput methodologies and toxicological relevance. Arch Toxicol 85:873-899.
36. Lobo I. 2008. Chromosome Abnormalities and Cancer Cytogenetics. Nature Education 1:1.
37. Ma J, Gao M, Lu Y, Feng X, Zhang J, Lin D, Xiao T, Hu Z, Yuan J, Su K, Shipley J, Xue J, Gao Y. 2006. Gain of 1q25-32, 12q23-24.3, and 17q12-22 facilitates tumorigenesis and progression of human squamous cell lung cancer. J Pathol 210:205-213.
38. Masuda A, Takahashi T. 2002. Chromosome instability in human lung cancers: possible underlying mechanisms and potential consequences in the pathogenesis. Oncogene 21:6884-6897.
39. Pei J, Balsara BR, Li W, Litwin S, Gabrielson E, Feder M, Jen J, Testa JR. 2001. Genomic imbalances in human lung adenocarcinomas and squamous cell carcinomas. Genes Chromosomes Cancer 31:282-287.
40. Qian J, Massion PP. 2008. Role of chromosome 3q amplification in lung cancer. J Thorac Oncol 3:212-215.
41. Ramos AH, Dutt A, Mermel C, Perner S, Cho J, Lafargue CJ, Johnson LA, Stiedl AC, Tanaka KE, Bass AJ, Barretina J, Weir BA, Beroukhim R, Thomas RK, Minna JD, Chirieac LR, Lindeman NI, Giordano T, Beer DG, Wagner P, Wistuba, II, Rubin MA, Meyerson M. 2009. Amplification of chromosomal segment 4q12 in non-small cell lung cancer. Cancer Biol Ther 8:2042-2050.
42. Saldivar JC, Shibata H, Huebner K. 2010. Pathology and biology associated with the fragile fhit gene and gene product. J Cell Biochem 109:858-865.
43. Sanchez-Cespedes M. 2011. The role of Lkb1 in lung cancer. Fam Cancer 10:447-453.
44. Sanz-Ortega J, Roig F, Al-Mousa MM, Saez MC, Munoz A, Sanz-Esponera J, Callol L. 2007. 17p13 (P53 Locus), 5q21 (Apc Locus) and 9p21 (P16 Locus) allelic deletions are frequently found in oral exfoliative cytology cells from smoker patients with non-small-cell lung cancer. Histol Histopathol 22:541-545.
45. Scesnaite A, Jarmalaite S, Mutanen P, Anttila S, Nyberg F, Benhamou S, Boffetta P, Husgafvel-Pursiainen K. 2012. Similar DNA methylation pattern in lung tumours from smokers and never-smokers with second-hand tobacco smoke exposure. Mutagenesis 4:423-429.
46. Schwartz AG, Wenzlaff AS, Bock CH, Ruterbusch JJ, Chen W, Cote ML, Artis AS, Van Dyke AL, Land SJ, Harris CC, Pine SR, Spitz MR, Amos CI, Levin AM, McKeigue PM. 2011. Admixture mapping of lung cancer in 1812 African-Americans. Carcinogenesis 32:312-317.
47. Soler Artigas M, Loth DW, Wain LV, Gharib SA, Obeidat M, Tang W, Zhai G, Zhao JH, Smith AV, Huffman JE, Albrecht E, Jackson CM, Evans DM, Cadby G, Fornage M, Manichaikul A, Lopez LM, Johnson T, Aldrich MC, Aspelund T, Barroso I, Campbell H, Cassano PA, Couper DJ, Eiriksdottir G, Franceschini N, Garcia M, Gieger C, Gislason GK, Grkovic I, Hammond CJ, Hancock DB, Harris TB, Ramasamy A, Heckbert SR, Heliovaara M, Homuth G, Hysi PG, James AL, Jankovic S, Joubert BR, Karrasch S, Klopp N, Koch B, Kritchevsky SB, Launer LJ, Liu Y, Loehr LR, Lohman K, Loos RJ, Lumley T, Al Balushi KA, Ang WQ, Barr RG, Beilby J, Blakey JD, Boban M, Boraska V, Brisman J, Britton JR, Brusselle GG, Cooper C, Curjuric I, Dahgam S, Deary IJ, Ebrahim S, Eijgelsheim M, Francks C, Gaysina D, Granell R, Gu X, Hankinson JL, Hardy R, Harris SE, Henderson J, Henry A, Hingorani AD, Hofman A, Holt PG, Hui J, Hunter ML, Imboden M, Jameson KA, Kerr SM, Kolcic I, Kronenberg F, Liu JZ, Marchini J, McKeever T, Morris AD, Olin AC, Porteous DJ, Postma DS, Rich SS, Ring SM, Rivadeneira F, Rochat T, Sayer AA, Sayers I, Sly PD, Smith GD, Sood A, Starr JM, Uitterlinden AG, Vonk JM, Wannamethee SG, Whincup PH, Wijmenga C, Williams OD, Wong A, Mangino M, Marciante KD, McArdle WL, Meibohm B, Morrison AC, North KE, Omenaas E, Palmer LJ, Pietilainen KH, Pin I, Pola Sbreve Ek O, Pouta A, Psaty BM, Hartikainen AL, Rantanen T, Ripatti S, Rotter JI, Rudan I, Rudnicka AR, Schulz H, Shin SY, Spector TD, Surakka I, Vitart V, Volzke H, Wareham NJ, Warrington NM, Wichmann HE, Wild SH, Wilk JB, Wjst M, Wright AF, Zgaga L, Zemunik T, Pennell CE, Nyberg F, Kuh D, Holloway JW, Boezen HM, Lawlor DA, Morris RW, Probst-Hensch N, Kaprio J, Wilson JF, Hayward C, Kahonen M, Heinrich J, Musk AW, Jarvis DL, Glaser S, Jarvelin MR, Ch Stricker BH, Elliott P, O'Connor GT, Strachan DP, London SJ, Hall IP, Gudnason V, Tobin MD. 2011. Genome-wide association and large-scale follow up identifies 16 new loci influencing lung function. Nat Genet 43:1082-1090.
48. Thun MJ, Lally CA, Flannery JT, Calle EE, Flanders WD, Heath CW, Jr. 1997. Cigarette smoking and changes in the histopathology of lung cancer. J Natl Cancer Inst 89:1580-1586.
49. Wali A. 2010. Fhit: Doubts are clear now. Scientific WorldJ 10:1142-1151.
50. Wassenaar CA, Dong Q, Wei Q, Amos CI, Spitz MR, Tyndale RF. 2011. Relationship between Cyp2a6 and Chrna5-Chrna3-Chrnb4 variation and smoking behaviors and lung cancer risk. J Natl Cancer Inst 103:1342-1346.
51. Weaver BA, Silk AD, Montagna C, Verdier-Pinard P, Cleveland DW. 2007. Aneuploidy acts both oncogenically and as a tumor suppressor. Cancer Cell 11:25-36.
52. Weitberg AB, Corvese D. 1993. Oxygen radicals potentiate the genetic toxicity of tobacco-specific nitrosamines. Clin Genet 43:88-91.
53. Wrage M, Ruosaari S, Eijk PP, Kaifi JT, Hollmen J, Yekebas EF, Izbicki JR, Brakenhoff RH, Streichert T, Riethdorf S, Glatzel M, Ylstra B, Pantel K, Wikman H. 2009. Genomic profiles associated with early micrometastasis in lung cancer: Relevance of 4q deletion. Clin Cancer Res 15:1566-1574.
54. Wu X, Hsu TC, Cao S, Lee JJ, Amos CI, Spitz MR. 1998. Deletion in poly(adp-ribose)polymerase pseudogene and lung cancer risk. Carcinogenesis 19:93-98.
55. Young RP, Whittington CF, Hopkins RJ, Hay BA, Epton MJ, Black PN, Gamble GD. 2010. Chromosome 4q31 locus in Copd is also associated with lung cancer. Eur Respir J 36:1375-1382.
56. Young RP, Hopkins RJ. 2011. How the genetics of lung cancer may overlap with copd. Respirology 16:1047-1055.